Cardiac Pathways gets go-ahead for ablation catheters:
This article was originally published in Clinica
Cardiac Pathways has received pre-market approval (PMA) for its Chillirpm cooled ablation catheters, including the company's Real-time Position Management navigation technology. The device includes a bi-directional steering capability and integrates the company's ultrasound transducer technology for dynamic real-time catheter navigation and visualisation. The PMA provides the additional approval necessary to use the RPM technology for therapy, the Sunnyvale, California-based company said.
You may also be interested in...
GSK is transferring technology to make its malaria vaccine antigen to Bharat Biotech and by 2029 will also transfer rights to supply the vaccine to WHO-approved immunization programs. The deal is expected to improve access via lower cost of the vaccine for such programs
Rules covering OTC medical devices, herbals and online activities have been added for the first time to the Irish Pharmaceutical Healthcare Association's Self-Care Advertising Code.
HBW Insight extracts five key lessons from 2020, the year the coronavirus pandemic swept its way across Europe.